AAAAAA
Results: 1-25/37
Authors:
VASSILOPOULOUSELLIN R
Citation: R. Vassilopoulousellin, CLINICAL OUTCOME OF 50 PATIENTS WITH MALIGNANT ABDOMINAL PARAGANGLIOMAS AND MALIGNANT PHEOCHROMOCYTOMAS, Endocrine-related cancer, 5(1), 1998, pp. 59-68
Authors:
VASSILOPOULOUSELLIN R
EFTEKHARI F
ATER JL
Citation: R. Vassilopoulousellin et al., ACCELERATED LOWER-EXTREMITY EPIPHYSEAL MATURATION IN A PREPUBERTAL, GROWTH HORMONE-DEFICIENT GIRL AFTER TREATMENT FOR SACRAL GANGLIONEUROBLASTOMA, International journal of pediatric hematology/oncology, 5(1), 1998, pp. 35-39
Authors:
VASSILOPOULOUSELLIN R
GOEPFERT H
RANEY B
SCHULTZ PN
Citation: R. Vassilopoulousellin et al., DIFFERENTIATED THYROID-CANCER IN CHILDREN AND ADOLESCENTS - CLINICAL OUTCOME AND MORTALITY AFTER LONG-TERM FOLLOW-UP, Head & neck, 20(6), 1998, pp. 549-555
Authors:
EVANS HL
VASSILOPOULOUSELLIN R
Citation: Hl. Evans et R. Vassilopoulousellin, HURTHLE CELL AND FOLLICULAR CARCINOMAS OF THE THYROID - A COMPARATIVE-STUDY, Modern pathology, 11(1), 1998, pp. 56-56
Authors:
HEADLEY JA
THERIAULT RL
LEBLANC AD
VASSILOPOULOUSELLIN R
HORTOBAGYI GN
Citation: Ja. Headley et al., PILOT-STUDY OF BONE-MINERAL DENSITY IN BREAST-CANCER PATIENTS TREATEDWITH ADJUVANT CHEMOTHERAPY, Cancer investigation, 16(1), 1998, pp. 6-11
Authors:
YEUNG SCJ
ETON O
BURTON DW
DEFTOS LJ
VASSILOPOULOUSELLIN R
GAGEL RF
Citation: Scj. Yeung et al., HYPERCALCEMIA DUE TO PARATHYROID HORMONE-RELATED PROTEIN SECRETION BYMELANOMA, Hormone research, 49(6), 1998, pp. 288-291
Authors:
YEUNG SCJ
CHIU AC
VASSILOPOULOUSELLIN R
GAGEL RF
Citation: Scj. Yeung et al., THE ENDOCRINE EFFECTS OF NONHORMONAL ANTINEOPLASTIC THERAPY, Endocrine reviews, 19(2), 1998, pp. 144-172
Authors:
HOFF AO
VASSILOPOULOUSELLIN R
Citation: Ao. Hoff et R. Vassilopoulousellin, THE ROLE OF GLUCAGON ADMINISTRATION IN THE DIAGNOSIS AND TREATMENT OFPATIENTS WITH TUMOR HYPOGLYCEMIA, Cancer, 82(8), 1998, pp. 1585-1592
Authors:
VASSILOPOULOUSELLIN R
THERIAULT R
KLEIN MJ
Citation: R. Vassilopoulousellin et al., ESTROGEN REPLACEMENT THERAPY IN WOMEN WITH PRIOR DIAGNOSIS AND TREATMENT FOR BREAST-CANCER, Gynecologic oncology, 65(1), 1997, pp. 89-93
Authors:
VASSILOPOULOUSELLIN R
Citation: R. Vassilopoulousellin, ESTROGEN REPLACEMENT THERAPY AFTER TREATMENT FOR LOCALIZED BREAST-CARCINOMA - PATIENT RESPONSES AND OPINIONS (VOL 78, PG 1043, 1996), Cancer, 79(4), 1997, pp. 867-867
Authors:
VASSILOPOULOUSELLIN R
KLEIN MJ
Citation: R. Vassilopoulousellin et Mj. Klein, PHYSICAL GROWTH-PARAMETERS IN CHILDREN TREATED FOR MALIGNANT DISEASES, International journal of pediatric hematology/oncology, 3(3), 1996, pp. 213-219
Authors:
VASSILOPOULOUSELLIN R
DELPASSAND ES
Citation: R. Vassilopoulousellin et Es. Delpassand, FOLLICULAR THYROID-CANCER - CLINICAL OUTCOME AND IMPACT OF RADIOIODINE THERAPY IN PATIENTS WITH DISTANT METASTASES, International journal of oncology, 8(5), 1996, pp. 969-976
Authors:
VASSILOPOULOUSELLIN R
EFTEKHARI F
ATER JL
Citation: R. Vassilopoulousellin et al., ACCELERATED LOWER-EXTREMITY EPIPHYSEAL MATURATION AFTER TREATMENT FORSACRAL NEUROBLASTOMA, Journal of bone and mineral research, 11, 1996, pp. 500-500
Authors:
VASSILOPOULOUSELLIN R
Citation: R. Vassilopoulousellin, PRECOCIOUS PUBERTY, GROWTH-HORMONE DEFICIENCY, AND NEUROFIBROMATOSIS, The Journal of pediatrics, 128(1), 1996, pp. 166-166
Authors:
VASSILOPOULOUSELLIN R
Citation: R. Vassilopoulousellin, GLUCAGON TREATMENT IN NICTH, The Journal of clinical endocrinology and metabolism, 81(4), 1996, pp. 1671-1671
Authors:
VASSILOPOULOUSELLIN R
KLEIN MJ
Citation: R. Vassilopoulousellin et Mj. Klein, ESTROGEN REPLACEMENT THERAPY AFTER TREATMENT FOR LOCALIZED BREAST-CARCINOMA - PATIENT RESPONSES AND OPINIONS, Cancer, 78(5), 1996, pp. 1043-1048
Authors:
VASSILOPOULOUSELLIN R
SCHULTZ PN
HAYNIE TP
Citation: R. Vassilopoulousellin et al., CLINICAL OUTCOME OF PATIENTS WITH PAPILLARY THYROID-CARCINOMA WHO HAVE RECURRENCE AFTER INITIAL RADIOACTIVE IODINE THERAPY, Cancer, 78(3), 1996, pp. 493-501
Authors:
VASSILOPOULOUSELLIN R
THIELVOLDT D
MARKOWITZ AB
Citation: R. Vassilopoulousellin et al., EFFECTS OF INTERLEUKIN-4 ADMINISTRATION ON ENDOCRINE FUNCTION AND LIPID PROFILE OF PATIENTS WITH MALIGNANT DISEASES, Blood, 87(9), 1996, pp. 4022-4023
Authors:
EVANS HL
VASSILOPOULOUSELLIN R
Citation: Hl. Evans et R. Vassilopoulousellin, ADRENAL-CORTICAL NEOPLASMS - A STUDY OF 56 CASES, American journal of clinical pathology, 105(1), 1996, pp. 76-86
Authors:
VASSILOPOULOUSELLIN R
KUDELKA AP
KAVANAGH JJ
EDWARDS CL
VADHANRAJ S
Citation: R. Vassilopoulousellin et al., EFFECTS OF INTERLEUKIN-1-ALPHA - ADMINISTRATION ON PITUITARY-ADRENAL AND PITUITARY-THYROID AXES FUNCTION OF PATIENTS WITH OVARIAN-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 17(2), 1995, pp. 109-113
Authors:
VASSILOPOULOUSELLIN R
KLEIN MJ
MOORE BD
REID HL
ATER J
ZIETZ HA
Citation: R. Vassilopoulousellin et al., EFFICACY OF GROWTH-HORMONE REPLACEMENT THERAPY IN CHILDREN WITH ORGANIC GROWTH-HORMONE DEFICIENCY AFTER CRANIAL IRRADIATION, Hormone research, 43(5), 1995, pp. 188-193
Authors:
HAYNIE TP
VASSILOPOULOUSELLIN R
Citation: Tp. Haynie et R. Vassilopoulousellin, HOW SAFE FOR THE PATIENT IS I-131 THERAPY FOR DIFFERENTIATED THYROID-CARCINOMA, The Journal of nuclear medicine, 36(1), 1995, pp. 27-28
Authors:
VASSILOPOULOUSELLIN R
Citation: R. Vassilopoulousellin, ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS, JAMA, the journal of the American Medical Association, 273(8), 1995, pp. 620-620
Authors:
VASSILOPOULOUSELLIN R
LIBSHITZ HI
HAYNIE TP
Citation: R. Vassilopoulousellin et al., PAPILLARY THYROID-CANCER WITH PULMONARY METASTASES BEGINNING IN CHILDHOOD - CLINICAL COURSE OVER 3 DECADES, Medical and pediatric oncology, 24(2), 1995, pp. 119-122
Authors:
LEE JE
BERGER DH
ELNAGGAR AK
HICKEY RC
VASSILOPOULOUSELLIN R
GAGEL RF
BURGESS MA
EVANS DB
Citation: Je. Lee et al., SURGICAL-MANAGEMENT, DNA CONTENT, AND PATIENT SURVIVAL IN ADRENAL-CORTICAL CARCINOMA, Surgery, 118(6), 1995, pp. 1090-1098